PIONEER-ALS
"PIONEER-ALS" is a word mark owned by VectorY B.V., filed at the EUIPO on February 6, 2026. It is registered and covers classes 5, 42 and 44.
- Status
- Registered
- Since July 2, 2026
- Filed
- February 6, 2026
- Registered
- July 1, 2026
- Expires
- February 6, 2036
- Application no.
- 019313953
- Registration no.
- 019313953
- Office
- EUIPO
- European Union Intellectual Property Office
- Mark type
- Word mark
- 3 classes
Who owns PIONEER-ALS
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
VectorY B.V.
Representative
Algemeen Octrooi- En Merkenbureau B.V.
Algemeen Octrooi- En Merkenbureau B.V
What the mark covers
The products and services PIONEER-ALS is filed for, grouped by Nice class.
Viral systems, Gene therapy systems, Nucleic acid delivery systems, namely viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors; Siccatives [drying agents] for medical purposes; Pharmaceuticals; Biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; Pharmaceutical preparations, vaccines, prophylaxis products and other pharmaceutical products for use in the following fields: nucleic acid-based therapy, Gene therapy and Cell therapy; Pharmaceutical products for use in gene therapy; Pharmaceuticals For use in antibody-based gene therapy
Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics; Conducting of clinical studies; research and advisory services relating to gene therapy; Research in the field of antibody-based gene therapy
Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consulting services in the field of pharmaceuticals; Gene therapy; Antibody-based gene therapy; Healthcare services in connection with gene therapy
What has happened so far
Steps recorded by the EUIPO, newest first.
- Bulletin 2026/122 Section B.1
- Bulletin 2026/055 Section A.1
About PIONEER-ALS
Who owns the trademark "PIONEER-ALS"?
The EUIPO trademark "PIONEER-ALS" (application 019313953) is owned by VectorY B.V.
What is the status of "PIONEER-ALS"?
Its status at the EUIPO is: registered.
When was "PIONEER-ALS" registered?
It was registered on July 1, 2026 and is due to expire on February 6, 2036.
Get this data via the API
Everything on this page comes from the Signa API. Pull PIONEER-ALS and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d492b-42f7-759d-8f58-5a362e12f895
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d492b-42f7-759d-8f58-5a362e12f895",
"object": "trademark",
"mark_text": "PIONEER-ALS",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "EM",
"application_number": "019313953",
"filing_date": "2026-02-06",
"nice_classes": [
5,
42,
44
],
"owners": [
{
"name": "VectorY B.V.",
"entity_id": "ent_019ebb7b-d751-72a9-b0b0-f1cd975a5859"
}
]
}